[


Journal

Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974

Informations de publication

Date de publication:
11 Mar 2023
Historique:
received: 07 11 2022
accepted: 23 02 2023
entrez: 11 3 2023
pubmed: 13 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

Reactive gliosis is a common pathological hallmark of CNS pathology resulting from neurodegeneration and neuroinflammation. In this study we investigate the capability of a novel monoamine oxidase B (MAO-B) PET ligand to monitor reactive astrogliosis in a transgenic mouse model of Alzheimer`s disease (AD). Furthermore, we performed a pilot study in patients with a range of neurodegenerative and neuroinflammatory conditions. A cross-sectional cohort of 24 transgenic (PS2APP) and 25 wild-type mice (age range: 4.3-21.0 months) underwent 60 min dynamic [ We selected the cerebellum as a pseudo-reference region based on the immunohistochemical comparison of age-matched PS2APP and WT mice. Subsequent PET imaging revealed that PS2APP mice showed elevated hippocampal and thalamic [ [

Identifiants

pubmed: 36906584
doi: 10.1186/s12974-023-02749-2
pii: 10.1186/s12974-023-02749-2
pmc: PMC10007845
doi:

Substances chimiques

Amyloid beta-Peptides 0
Monoamine Oxidase EC 1.4.3.4
Receptors, GABA 0
TSPO protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : EXC 2145 SyNergy - ID 390857198

Informations de copyright

© 2023. The Author(s).

Références

Brain. 2017 Sep 1;140(9):2460-2474
pubmed: 29050386
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
JAMA Neurol. 2020 Nov 1;77(11):1408-1419
pubmed: 33165511
Transl Psychiatry. 2021 Jan 11;11(1):27
pubmed: 33431793
Proc Natl Acad Sci U S A. 1982 Oct;79(20):6385-9
pubmed: 6755469
Front Mol Neurosci. 2017 Dec 19;10:427
pubmed: 29311817
J Nucl Med. 2016 Jun;57(6):954-60
pubmed: 26912428
Science. 1987 Jan 23;235(4787):481-5
pubmed: 3099392
Neuroscience. 2005;135(4):1203-15
pubmed: 16165303
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2202-8
pubmed: 21853308
Neurochem Int. 2011 Jan;58(1):60-8
pubmed: 21075154
J Cereb Blood Flow Metab. 2014 May;34(5):883-9
pubmed: 24517979
Mol Imaging Biol. 2018 Aug;20(4):605-614
pubmed: 29297157
J Nucl Med. 2022 Jan;63(1):117-124
pubmed: 34016733
Cell. 2017 Jun 15;169(7):1276-1290.e17
pubmed: 28602351
J Nucl Med. 2020 Dec;61(12):1825-1831
pubmed: 32414948
Theranostics. 2021 Aug 19;11(18):8964-8976
pubmed: 34522221
Sci Transl Med. 2021 Oct 13;13(615):eabe5640
pubmed: 34644146
Front Neurosci. 2016 Feb 29;10:45
pubmed: 26973442
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
J Nucl Med. 2012 Jan;53(1):37-46
pubmed: 22213821
Trends Mol Med. 2019 Feb;25(2):77-95
pubmed: 30611668
Lancet. 2011 Mar 19;377(9770):1019-31
pubmed: 21371747
Brain. 2019 Oct 1;142(10):3116-3128
pubmed: 31504212
Neurology. 2021 May 5;:
pubmed: 33952650
Trends Neurosci. 2009 Dec;32(12):638-47
pubmed: 19782411
Nat Neurosci. 2021 Mar;24(3):312-325
pubmed: 33589835
J Neurosci. 2003 Oct 1;23(26):8989-9003
pubmed: 14523101
J Nucl Med. 2022 Oct;63(10):1560-1569
pubmed: 35086892
J Nucl Med. 2016 Feb;57(2):315-20
pubmed: 26585057
J Cereb Blood Flow Metab. 1990 Sep;10(5):740-7
pubmed: 2384545
Front Aging Neurosci. 2019 Sep 11;11:249
pubmed: 31572166
Neurodegener Dis. 2009;6(1-2):29-36
pubmed: 19066434
J Nucl Med. 2019 Dec;60(12):1787-1793
pubmed: 31302633
Alzheimers Dement. 2020 Apr;16(4):681-695
pubmed: 31879236
J Nucl Med. 2013 Jul;54(7):1127-34
pubmed: 23729696
Neurochem Res. 2000 Oct;25(9-10):1439-51
pubmed: 11059815
J Neuroinflammation. 2020 Dec 14;17(1):374
pubmed: 33317543
J Nucl Med. 2022 Oct;63(10):1551-1559
pubmed: 35086898
J Neuroinflammation. 2021 Jun 3;18(1):124
pubmed: 34082772
Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1119-32
pubmed: 25893384
Front Neurosci. 2022 Feb 08;16:807435
pubmed: 35210989
Brain. 2016 Mar;139(Pt 3):922-36
pubmed: 26813969

Auteurs

Anna Ballweg (A)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Carolin Klaus (C)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Letizia Vogler (L)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Sabrina Katzdobler (S)

Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.

Karin Wind (K)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Artem Zatcepin (A)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Sibylle I Ziegler (SI)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Birkan Secgin (B)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Florian Eckenweber (F)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Bernd Bohr (B)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Alexander Bernhardt (A)

Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.

Urban Fietzek (U)

Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.

Boris-Stephan Rauchmann (BS)

Department of Radiology, University Hospital of Munich, LMU Munich, Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, Munich, Germany.

Sophia Stoecklein (S)

Department of Radiology, University Hospital of Munich, LMU Munich, Munich, Germany.

Stefanie Quach (S)

Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.

Leonie Beyer (L)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Maximilian Scheifele (M)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Marcel Simmet (M)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Emanuel Joseph (E)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Simon Lindner (S)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Isabella Berg (I)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.

Norman Koglin (N)

Life Molecular Imaging GmbH, Berlin, Germany.

Andre Mueller (A)

Life Molecular Imaging GmbH, Berlin, Germany.

Andrew W Stephens (AW)

Life Molecular Imaging GmbH, Berlin, Germany.

Peter Bartenstein (P)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Joerg C Tonn (JC)

Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Nathalie L Albert (NL)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Tania Kümpfel (T)

Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Munich, Germany.

Martin Kerschensteiner (M)

Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Munich, Germany.
Biomedical Center, Faculty of Medicine, LMU Munich, Munich, Germany.

Robert Perneczky (R)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital of Munich, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College, London, UK.
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.

Johannes Levin (J)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Lars Paeger (L)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Jochen Herms (J)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.

Matthias Brendel (M)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Marchioninistr.15, 81377, Munich, Germany. matthias.brendel@med.uni-muenchen.de.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. matthias.brendel@med.uni-muenchen.de.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. matthias.brendel@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH